Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines

Yoshiko Kashiwagi1, Kuniko Horie, Chikako Kanno

  • 1Department of Ocular Cellular Engineering, Yamagata University Faculty of Medicine, Yamagata City, Yamagata, Japan. kasiwagi@med.id.yamagata-u.ac.jp

Abstract

Insights

Trichostatin A (TSA) increases transforming growth factor-beta type II receptor (TbetaR-II) gene expression and activates its promoter in retinoblastoma cells, inhibiting cell growth. However, TSA alone does not restore TGF-beta signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Retinoblastoma, a childhood eye cancer, stems from mutations in the RB tumor-suppressor gene.
  • Retinoblastoma cells often resist transforming growth factor-beta (TGF-beta) due to a lack of TGF-beta type II receptor (TbetaR-II) expression.
  • Trichostatin A (TSA), a histone deacetylase inhibitor, has shown potential in inducing TbetaR-II gene expression in other cancer cells.

Purpose of the Study:

  • To investigate the impact of TSA on TbetaR-II gene expression in retinoblastoma cells.
  • To determine if TSA can modulate TbetaR-II promoter activity and related signaling pathways.
  • To assess the effect of TSA on retinoblastoma cell proliferation.

Main Methods:

  • Utilized four retinoblastoma cell lines transfected with a TbetaR-II promoter-luciferase reporter construct.
  • Assessed TbetaR-II mRNA and protein expression via RT-PCR and Western blot.
  • Evaluated TbetaR-II promoter activity using luciferase assays and analyzed TGF-beta signaling and cell viability.

Main Results:

  • TSA treatment significantly induced TbetaR-II mRNA expression in retinoblastoma cells.
  • Activation of the TbetaR-II promoter was observed following TSA administration.
  • TSA inhibited retinoblastoma cell growth, but did not restore TGF-beta-related signaling pathways.

Conclusions:

  • TSA effectively upregulates TbetaR-II mRNA expression and promoter activity in retinoblastoma cells.
  • The observed cell growth inhibition by TSA may not be directly linked to TbetaR-II re-expression or TGF-beta pathway restoration.
  • Further research is needed to elucidate the precise mechanisms of TSA's anti-proliferative effects in retinoblastoma.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...